The BPC-157 Layer: Addresses the structural side (protecting the gut lining from the GI distress GLP-1s often cause, and potentially mitigating the severe muscle loss that accompanies rapid weight reduction)
Frequently asked questions Is BPC-157 safe for people with liver disease
Until well-designed clinical trials are conducted, BPC-157 should be considered investigational, and its use approached with caution
From there, care can include peptide therapy, anti-aging treatments, GLP-1 weight loss (semaglutide and tirzepatide), NAD+ therapy, hormone optimization, and recovery support
Recalls & Warnings November 20, 2020 FTC Files Complaint Against Two Supplement Companies for Deceptive Marketing On November 20, 2020, the FTC approved a Part 3 administrative complaint against Health Research Laboratories, LLC, its owner Kramer Duhon, and Whole Body Supplements, LLC for making unverified claims that their products can prevent or treat diseases